Azadzoi Kazem M, Heim Vanessa K, Tarcan Tufan, Siroky Mike B
Urology Research (151), Boston University School of Medicine and VA Boston Medical Center, 150 South Huntington Avenue, Boston, MA 02130, USA.
Neurourol Urodyn. 2004;23(3):258-64. doi: 10.1002/nau.20029.
Previously we showed that ischemia alters bladder smooth muscle contractility in the rabbit. This study investigates the role of urothelium and eicosanoid-release in ischemic bladder smooth muscle instability.
Male New Zealand white rabbits were divided into treated (n = 12) and age-matched control (n = 10) groups. The treated group underwent balloon endothelial injury of the iliac arteries, and then received 4 weeks of cholesterol diet, followed by 4 weeks of regular diet. The control group received a regular diet for 8 weeks. After 8 weeks, blood flow for both the iliac arteries and the bladder as well as bladder oxygen tension were recorded. In one-half of each ischemic and control bladder, the urothelium was removed. Bladder tissues were processed for organ bath and enzyme-immunoassay (EIA) of prostaglandins (PGs) and leukotrienes (LTs).
A significant decrease in iliac arterial blood flow, bladder wall blood flow, and bladder oxygen tension was found in the treated group. Bladder ischemia increased the frequency and amplitude of baseline spontaneous smooth muscle contractility. Ischemic tissues with urothelium (Uro+) demonstrated significant increases in the contractile response to electrical field stimulation (EFS) and carbachol relative to control Uro+ tissues. Urothelial removal increased smooth muscle contraction in the control tissues but had no significant effect in the ischemic/hypoxic tissues. Contraction of control tissues without urothelium (Uro-) was similar to contraction of ischemic Uro+ tissues. Contractions of ischemic Uro+ and control Uro- tissues were unchanged after treatment with the cyclooxygenase (COX) inhibitor indomethacin, while they were significantly reduced by the 5-lipoxygenase (5-LO) inhibitor NDGA. EIA showed no change in PGs release from the ischemic urothelium, but significant increase in PGF(2-alpha) and thromboxane A(2) release from the ischemic suburothelial tissue. Ischemia increased the release of LTB(4), LTC(4), and LTE(4) from both urothelium and suburothelial tissue.
Our studies suggest loss of urothelial-mediated tone and LTs-mediated smooth muscle instability in the chronically ischemic/hypoxic bladder.
此前我们发现,缺血会改变兔膀胱平滑肌的收缩性。本研究旨在探究尿路上皮和类花生酸释放对缺血性膀胱平滑肌不稳定性的作用。
将雄性新西兰白兔分为治疗组(n = 12)和年龄匹配的对照组(n = 10)。治疗组接受髂动脉球囊内皮损伤,然后给予4周高胆固醇饮食,随后给予4周常规饮食。对照组接受8周常规饮食。8周后,记录髂动脉和膀胱的血流以及膀胱氧分压。在每组缺血和对照膀胱的一半中,去除尿路上皮。将膀胱组织用于器官浴以及前列腺素(PGs)和白三烯(LTs)的酶免疫测定(EIA)。
治疗组髂动脉血流、膀胱壁血流和膀胱氧分压显著降低。膀胱缺血增加了基线自发平滑肌收缩的频率和幅度。与对照尿路上皮完整(Uro+)组织相比,尿路上皮完整的缺血组织对电场刺激(EFS)和卡巴胆碱的收缩反应显著增加。去除尿路上皮增加了对照组织中的平滑肌收缩,但对缺血/缺氧组织无显著影响。无尿路上皮(Uro-)的对照组织的收缩与缺血尿路上皮完整组织的收缩相似。用环氧化酶(COX)抑制剂吲哚美辛处理后,缺血尿路上皮完整组织和对照无尿路上皮组织的收缩未改变,而用5-脂氧合酶(5-LO)抑制剂NDGA处理后,它们的收缩显著降低。EIA显示缺血尿路上皮中PGs释放无变化,但缺血尿路上皮下组织中PGF(2-α)和血栓素A(2)释放显著增加。缺血增加了尿路上皮和尿路上皮下组织中LTB(4)、LTC(4)和LTE(4)的释放。
我们的研究表明,在慢性缺血/缺氧膀胱中,尿路上皮介导的张力丧失以及LTs介导的平滑肌不稳定性。